*Company Description** Predicta Biosciences is a precision oncology company at the forefront of integrating multiomics and liquid biopsy technologies to advance cancer diagnosis and treatment. Its innovative diagnostic products eliminate the need for bone-marrow biopsies by using blood-based samples